descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2014 English Publisher:SAGE PublicationsJournal:Hospital Pharmacy, volume 49, pages 702-709 (issn: 0018-5787, eissn: 1945-1253,

Authors: Dominic A. Solimando; James Waddell;

doi: 10.1310/hpj4908-702

pmid: 25477594

pmc: PMC4252197

Drug Monographs: Ibrutinib and Ramucirumab

- Summary
- Related research
  (31)
- Metrics

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

31 Research products, page 1 of 4

Blinatumomab and Pembrolizumab
2015IsAmongTopNSimilarDocuments
Doxorubicin and Dacarbazine (AD) Regimen for Soft Tissue Sarcomas
2015IsAmongTopNSimilarDocuments
Paclitaxel and Trastuzumab for Breast Cancer
2014IsAmongTopNSimilarDocuments
Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide Regimen for Ewing's Sarcoma and Primitive Neuroectodermal Tumor (PNET) of Bone
2008IsAmongTopNSimilarDocuments
Cabazitaxel and Prednisone Regimen for Prostate Cancer
2015IsAmongTopNSimilarDocuments
Gemcitabine and Carboplatin (Renally Dosed) Regimen for Bladder Cancer
2015IsAmongTopNSimilarDocuments
Drug Monographs: Belinostat and Idelalisib
2014IsAmongTopNSimilarDocuments
Paclitaxel and Carboplatin (TC) Regimen for Ovarian Cancer
2014IsAmongTopNSimilarDocuments
Drug Monographs: Afatinib and Obinutuzumab
2014IsAmongTopNSimilarDocuments
Drug Monographs: Dabrafenib and Trametinib
2013IsAmongTopNSimilarDocuments

chevron_left
1
2
3
4
chevron_right

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average